Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium

Ocular Immunology and Inflammation

Volumn 14, Issue 2, 2006, Pages 99-104

  Kump, Leila I ^a,c   Cervantes Castañeda, René A ^a   Androudi, Sofia N ^a   Foster, C Stephen ^a   Christen, William G ^b  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

Pregnancy; Puerperium; Uveitis

Indexed keywords

ADULT; CHRONIC DISEASE; CHRONIC NONINFECTIOUS UVEITIS; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; MEDICAL RECORD REVIEW; PREGNANCY; PREGNANT WOMAN; PUERPERIUM; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; REVIEW; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; UVEITIS;

ADOLESCENT; ADULT; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT, NEWBORN; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; UVEITIS;

EID: 33645790531     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940500557027     Document Type: Review

References (52)

1. Progesterone in large amounts has immunosuppressive effect. J Am Med Assoc. 1976;236:905-913.
2. Shizume K, Lerner AB. Determination of melanocyte-stimulating hormone in urine and blood. J Clin Endoncrinol Metab. 1954;14:1491-1510.
3. Lipton JM, Catania A. Anti-inflammatory actions of the neuromodulator α-MSH. Immunol Today. 1997;18:140-145.
4. Lipton JM. Modulation of host defense by the neuropeptide α-MSH. Yale J Biol Med. 1990;63:173-182.
5. Holdeman M, Khorram O, Samson WK, et al. Fever-specific changes in central MSH and CRF concentrations. Am J Physiol. 1985;248:R125-R129.
6. Watanabe T, Hiltz ME, Catania A, et al. Inhibition of IL-1β-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH. Brain Res Bull. 1993;32:311-314.
7. Martin LW, Catania A, Hiltz ME, et al. Neuropeptide alpha-MSH antagonizes IL-6 and TNF-induced fever. Peptides. 1991;12:297-299.
8. Taylor AW. Ocular immunosuppressive microenvironment. In: Streilein JW, editor. Immune response and the eye. Basel: Karger, 1991;72-89.
9. Belanger L, Waithe WI, Daguillard F, et al., editors. Alpha-Fetoprotein. Paris: Institut National de la Santé et de la Recherche Médicale, 1974.
10. Tomasi TB. Structure and function of α-fetoprotein. Annu Rev Med. 1977;28:453-465.
11. Chakraborty M, Mandal C. Immunosuppressive effect of human alpha-fetoprotein: a cross species study. Immunol Invest. 1993;22:329-339.
12. Matsuura E, Kang Y, Kitikawa H, et al. Modulation of T cell function by alpha-fetoprotein: an in vivo study on porcine thyroid peroxidase-induced experimental autoimmune thyroiditis in transgenic mice producing human alpha-fetoprotein. Tumor Biol. 1999;20:162-171.
13. Hoskin DW, Murgita RA. Specific maternal anti-fetal lymphoproliferative responses and their regulation by natural immunosuppressive factors. Clin Exp Immunol. 1989;76:262-267.
14. Aussel C, Fehlmann M. Effect of alpha-fetoprotein on arachidonic acid metabolism in a human T-cell line. Immunol Lett. 1987;14:133-137.
15. www.merrimackpharma.com
16. Taylor DD, Sullivan SA, Eblen AC, et al. Modulation of T-cell CD3-Zeta chain expression during normal pregnancy. J Reprod Immunol. 2002;54:15-31.
17. Qui H, Sun Y, He L. Study on the expression of Fas ligand on the surfaces of human cytotrophoblasts in normal pregnancy. J Tongjii Med Univ. 2000;20:166-168.
18. Piccini MP. T-cell cytokines in pregnancy. Am J Reprod Immunol. 2002;47:289-294.
19. White CA, Johansson M, Roberts CT, et al. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod. 2004;70:123-131.
20. Gorczynski RM, Hadidi S, Yu G, et al. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol. 2002;48:18-26.
21. Wegmann TG, Lin H, Guilbert L, et al. Bi-directional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today. 1993;14:353-356.
22. Piccini M-P, Scaletti C, Maggi E. Role of hormone controlled Th1 and Th2-type cytokines in successful pregnancy. J Neuroimmunol. 2000;109:30-33.
23. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266-271.
24. Ilias I, Mastorakos G. The emerging role of peripheral corticotrophin-releasing hormone. J Endocrinol Invest. 2003;26:364-371.
25. Harness J, Cavanagh A, Morton H, et al. A protective effect of early pregnancy factor on experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neurol Sci. 2003;216:33-41.
26. Frith JA, Mcleod JG. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1988;51:495-498.
27. Birk K, Ford C, Smeltzer S, et al. The clinical course of multiple sclerosis during pregnancy and puerperium. Arch Neurol. 1990;47:738-742.
28. Confavreux C, Hutchinson M, Hours M, et al. Rate of pregnancy related relapses in multiple sclerosis. N Engl J Med. 1998;339:285-291.
29. Sadovnick D, Eisen K, Hashimoto SA, et al. Pregnancy and multiple sclerosis. Arch Neurol. 1994;51:1120-1124.
30. Ruollet E, Verdier-Taillefer M-H, Amarenco P, et al. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry. 1993;56:1062-1065.
31. Runmarker B, Anderson O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain. 1995;118:253-261.
32. Poser S, Poser W. Multiple sclerosis and gestation. Neurology. 1983;33:1422-1427.
33. Damek DM, Shuster EA. Pregnancy and multiple sclerosis. Mayo Clin Proc. 1997;72:977-989.
34. Verdu P, Theys P, D'Hooghe MB, et al. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg. 1994;96:38-41.
35. De Silva JA, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol. 1992;11:189-194.
36. Ostensen M, Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 1983;26:1155-1159.
37. Barrett JH, Brennan P, Fiddler M, et al. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999;42:1219-1227.
38. Bang D, Chun YS, Haam IB, et al. The influence of pregnancy on Behcet's disease. Yonsei Med J. 1997;38:437-443.
39. Marsal S, Falga C, Simeon CP, et al. Behcet's disease and pregnancy relationship study. Br J Rheumatol. 1997;36:234-238.
40. Hamza M, Eleuch M, Zribi A. Behcet's disease and pregnancy. Ann Rheum Dis. 1988;47:350-352.
41. Farraq OA, Al-Suleiman SA, Bella H, et al. Behcet's disease and pregnancy. Aust NZ Obstet Gynaecol. 1987;27:161-163.
42. Hurt WG, Cooke LL, Jordan WP, et al. Behcet's syndrome associated with pregnancy. Obstet Gynecol. 1979;53:31S-33S.
43. Friedman Z, Granat M, Neumann E. The syndrome of Vogt-Koyanagi-Harada and pregnancy. Metab Pediatr Ophthalmol. 1980;4:147-149.
44. Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980;90:69-75.
45. Steahly LP. Vogt-Koyanagi-Harada syndrome and pregnancy. Ann Ophthalmol. 1990;22:59-62.
46. Nohara M, Norose K, Segawa K. Vogt-Koyanagi-Harada disease during pregnancy. Br J Ophthalmol. 1995;79:94-95.
47. Doi M, Matsubara H, Uji Y. Vogt-Koyanagi-Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids. Acta Ophthalmol Scand. 2000;78:93-96.
48. Miyata N, Sugita M, Nakamura S, et al. Treatment of Vogt-Koyanagi- Harada's disease during pregnancy. Jpn J Ophthalmol. 2001;45:177-180.
49. Chan CC, Reed GF, Kim Y, Agron E, Buggage RR. A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br J Ophthalmol. 2004;88:1506-1509.
50. Rabiah PK, Vitale AT. Non-infectious uveitis and pregnancy. Am J Ophthalmol. 2003;136:91-98.
51. Nelson L, Franklin GM, Jones MC, et al. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. J Am Med Assoc. 1988;259:3441-3443.
52. Kump LI, Androudi SN, Foster CS. Treatment of ocular toxoplasmosis in pregnancy. Clin Exp Ophthalmol. 2005;33:455-460.